Location History:
- Napa, CA (US) (2003 - 2017)
- American Canyon, CA (US) (2008 - 2017)
Company Filing History:
Years Active: 2003-2017
Title: Innovations in Nasal Drug Delivery: The Contributions of Imtiaz A Chaudry
Introduction
Imtiaz A Chaudry, based in American Canyon, CA, is a prolific inventor known for his significant contributions to the field of pharmaceutical formulations. With a remarkable portfolio of 27 patents, Chaudry has focused primarily on innovations that enhance drug delivery systems, particularly through nasal administration.
Latest Patents
Among his latest patents, Chaudry has developed nasal pharmaceutical formulations that incorporate a drug substance with a specific particle size distribution profile. This innovative formulation enhances bioavailability, efficacy, and therapeutic effects when administered intranasally. The patented formulations may include corticosteroids, such as fluticasone or its derivatives, to effectively treat symptoms of rhinitis. Additionally, he has worked on bronchodilating beta-agonist compositions suitable for nebulized aerosol administration, which provide effective treatment methods for bronchoconstrictive disorders.
Career Highlights
Chaudry has held significant positions at reputable companies in the pharmaceutical industry, including Dey L.P. and Mylan Specialty LP. His work has played a crucial role in the advancement of drug delivery technologies, particularly in enhancing the therapeutic impact of nasal medications.
Collaborations
Throughout his career, Chaudry has collaborated with notable colleagues such as Partha S Banerjee and Stephen Pham. These collaborations have fostered an environment of innovation and creativity, leading to the successful development of his patents.
Conclusion
Imtiaz A Chaudry's contributions to the field of pharmaceutical innovations have paved the way for advancements in nasal drug delivery systems. His extensive patent portfolio underscores his commitment to improving patient outcomes through effective and efficient drug formulations. As the pharmaceutical landscape continues to evolve, Chaudry's work remains vital to the future of innovative treatments.